Susanne Fix, MD
Neurological Surgery · Anchorage, AKNPI 1497866578
Payments from drug & device makers
What this record shows
Cerapedics Inc. accounts for 64.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $527 and has fallen 96.6% since, to $18 in 2024.
Across 12 payments — averaging $81.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cerapedics Inc.$632
- Johnson & Johnson$154
- Centinel Spine, LLC$111
- GT Medical Technologies, Inc$19
- Merz North America, Inc.$19
- Abbott$18
- plus $27 from 2 others
What the payments were for
- Speaking & faculty fees$50051%
- Food & beverage$48049%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cerapedics Inc. | 2 | $632 |
| Johnson & Johnson | 3 | $154 |
| Centinel Spine, LLC | 1 | $111 |
| GT Medical Technologies, Inc | 2 | $19 |
| Merz North America, Inc. | 1 | $19 |
| Abbott | 1 | $18 |
| Avanos Medical | 1 | $14 |
| Nevro Corp. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- i-FACTOR Putty$632
- PRODISC L$111
- VIPER$111
How this compares
Too few neurological surgery providers in Alaskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TymlosAbaloparatide | 14 | $34,677 |
| Gabapentin | 42 | $343 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $316 |
| Oxycodone Hcl | 13 | $274 |
| Baclofen | 20 | $266 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 23 | $236 |
| Pregabalin | 15 | $156 |
| Tramadol Hcl | 19 | $132 |
| Cyclobenzaprine Hcl | 19 | $71 |
| Diazepam | 22 | $62 |
| Trazodone Hcl | 12 | $53 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Anchorage
- Samuel WallerAnchorage$45K
- Estrada BernardAnchorage$29K
- Timothy CohenAnchorage$20K
- le HeAnchorage$18K
- Richard PerrinAnchorage$15K
- David PaulsonAnchorage$10K
- Brian MillerAnchorage$6K
- James BalesAnchorage$2K
- Louis KralickAnchorage$84
- Kim WrightAnchorage$77
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.